Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2015-07

AUTHORS

Enrico Vasile, Carmelo Tibaldi, G. Leticia Leon, Armida D’Incecco, Elisa Giovannetti

ABSTRACT

PURPOSE: Cytochrome P450 1B1 (CYP1B1) is involved in the metabolism of anticancer agents; its overexpression was associated with resistance to docetaxel, a commonly used drug for second-line treatment of NSCLC. Several functional single nucleotide polymorphisms (SNPs) have been associated with CYP1B1 expression and activity. The objective of this study was to retrospectively evaluate the correlation of CYP1B1 SNPs with the outcome of NSCLC patients treated with docetaxel in second or third line. METHODS: Associations between CYP1B1 4326C>G and 4390A>G polymorphisms with response, progression-free survival (PFS) and overall survival (OS) were estimated using Pearson χ(2) test, Kaplan-Meier curves and log-rank test; a multivariate analysis was performed using Cox proportional hazards modeling. RESULTS: A total of 65 advanced NSCLC patients were enrolled into the analysis. Median age was 66 years (range 46-81). Forty-nine patients were male; only five were never smokers. Performance status (PS) was 0 in 25 patients, 1 in 28 and 2 in 12. Histology was adenocarcinoma in 28 patients, squamous carcinoma in 22, other NSCLC in the remaining 15. At univariate analysis, stage and CYP1B1 4326C>G SNPs are associated with PFS, while PS and CYP1B1 4326C>G SNPs correlated with OS. In particular, patients with CYP1B1 4326-GG genotype had shorter PFS and OS than patients with other genotypes (PFS 1.80 vs. 2.70 months, p = 0.12; OS 3.63 vs. 9.83 months, p = 0.039). CYP1B1 4326C>G SNPs were also associated with response rate. Multivariate analysis confirmed the independent prognostic/predictive role of CYP1B1 4326C>G SNPs on OS (p = 0.042) with only a trend for PFS (p = 0.083). CONCLUSIONS: CYP1B1 4326C>G polymorphism emerged as possible prognostic/predictive marker of activity and efficacy of docetaxel in NSCLC patients. More... »

PAGES

1189-1194

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00432-014-1880-3

DOI

http://dx.doi.org/10.1007/s00432-014-1880-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047431410

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25504507


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Pharmacological", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP1B1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Docetaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Genetic Association Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polymorphism, Single Nucleotide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prognosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Taxoids", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Azienda Ospedaliera Universitaria Pisana", 
          "id": "https://www.grid.ac/institutes/grid.144189.1", 
          "name": [
            "Division of Medical Oncology 2, Department of Oncology, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vasile", 
        "givenName": "Enrico", 
        "id": "sg:person.01006607213.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006607213.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology, Azienda USL 6, Viale Alfieri 36, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tibaldi", 
        "givenName": "Carmelo", 
        "id": "sg:person.0631427704.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631427704.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of La Laguna", 
          "id": "https://www.grid.ac/institutes/grid.10041.34", 
          "name": [
            "Department of Oncology, VUMC, De Boelelaan 1117, Amsterdam, The Netherlands", 
            "Center for Biomedical Research of the Canary Islands, Instituto de Tecnologias Biomedicas, University of La Laguna, San Crist\u00f3bal de La Laguna, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leon", 
        "givenName": "G. Leticia", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Oncology, Azienda USL 6, Viale Alfieri 36, Livorno, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "D\u2019Incecco", 
        "givenName": "Armida", 
        "id": "sg:person.01152336274.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152336274.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Oncology, VUMC, De Boelelaan 1117, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Giovannetti", 
        "givenName": "Elisa", 
        "id": "sg:person.0577505063.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ab.2011.08.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004591949"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/mol.104.006056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004869238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.08.163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016594110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-07-0557", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017134170"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1541-7786.mcr-05-0101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021745176"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.2774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031223413"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3816/clc.2006.n.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033968801"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1124/dmd.30.11.1149", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041252912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6604195", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043379832", 
          "https://doi.org/10.1038/sj.bjc.6604195"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70310-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047147510"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0006-2952(01)00643-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047800103"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/canjclin.55.2.74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048020321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-10-511", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049101761", 
          "https://doi.org/10.1186/1471-2407-10-511"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.8251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052156977"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.tox.2004.08.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053362093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.12.046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204000"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138161213804547268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069168526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.10.2095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074640407"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.12.2354", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074654615"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-07", 
    "datePublishedReg": "2015-07-01", 
    "description": "PURPOSE: Cytochrome P450 1B1 (CYP1B1) is involved in the metabolism of anticancer agents; its overexpression was associated with resistance to docetaxel, a commonly used drug for second-line treatment of NSCLC. Several functional single nucleotide polymorphisms (SNPs) have been associated with CYP1B1 expression and activity. The objective of this study was to retrospectively evaluate the correlation of CYP1B1 SNPs with the outcome of NSCLC patients treated with docetaxel in second or third line.\nMETHODS: Associations between CYP1B1 4326C>G and 4390A>G polymorphisms with response, progression-free survival (PFS) and overall survival (OS) were estimated using Pearson \u03c7(2) test, Kaplan-Meier curves and log-rank test; a multivariate analysis was performed using Cox proportional hazards modeling.\nRESULTS: A total of 65 advanced NSCLC patients were enrolled into the analysis. Median age was 66 years (range 46-81). Forty-nine patients were male; only five were never smokers. Performance status (PS) was 0 in 25 patients, 1 in 28 and 2 in 12. Histology was adenocarcinoma in 28 patients, squamous carcinoma in 22, other NSCLC in the remaining 15. At univariate analysis, stage and CYP1B1 4326C>G SNPs are associated with PFS, while PS and CYP1B1 4326C>G SNPs correlated with OS. In particular, patients with CYP1B1 4326-GG genotype had shorter PFS and OS than patients with other genotypes (PFS 1.80 vs. 2.70 months, p = 0.12; OS 3.63 vs. 9.83 months, p = 0.039). CYP1B1 4326C>G SNPs were also associated with response rate. Multivariate analysis confirmed the independent prognostic/predictive role of CYP1B1 4326C>G SNPs on OS (p = 0.042) with only a trend for PFS (p = 0.083).\nCONCLUSIONS: CYP1B1 4326C>G polymorphism emerged as possible prognostic/predictive marker of activity and efficacy of docetaxel in NSCLC patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00432-014-1880-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "141"
      }
    ], 
    "name": "Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients", 
    "pagination": "1189-1194", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e1f2a7a2522e7dc9c7ff72847ade015f49a886605d5c3b4fabbe3d5bdd8f5ded"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25504507"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00432-014-1880-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047431410"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00432-014-1880-3", 
      "https://app.dimensions.ai/details/publication/pub.1047431410"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54328_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00432-014-1880-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00432-014-1880-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00432-014-1880-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00432-014-1880-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00432-014-1880-3'


 

This table displays all metadata directly associated to this object as RDF triples.

246 TRIPLES      21 PREDICATES      68 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00432-014-1880-3 schema:about N0d8e477ca5fa49d699b1713eb9bea4d9
2 N1727ed27c7d040c39f8cd03e2357ff15
3 N22afd925d2f94f6592b822fe5e507ef6
4 N32f28055ad394092af5d89e5140d0956
5 N35d3cab3f80e442cab4e7768002aa38f
6 N3c76dec90a9047229e310ec02a74f228
7 N41a2cd309cb44b938166f4e6a3815963
8 N4dbda8c393a944f29d9d06d04ddac19f
9 N5c29512f95c84c08881bba1a997e0abc
10 N65e57242c1a64c9db03a98745a55eb2e
11 N71b1f61b4d00462fa70f122ecfd30c9d
12 N72b12e48f99d4c0f9035e7dbc8cf60a2
13 N884dfd4283234d0e9572ebdd96470ca5
14 N8d58a64aafc1422ca031400aed3aa406
15 N9b942696158246309da4f195c608b0b4
16 Nac41e3ae7f1946638a1a9ab87628ada0
17 Nc832ff38f91a4f0da0adc0e220afd85c
18 Nd7428d19d4c549ff88425972b6e5511e
19 Ndc90e5a2445c484bbca932829e27a000
20 Ndcf690e7ef544f1b8512a7f11c66cc56
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author N1327a2b448624d6b8c94ab668ac43cbb
24 schema:citation sg:pub.10.1038/sj.bjc.6604195
25 sg:pub.10.1186/1471-2407-10-511
26 https://doi.org/10.1016/j.ab.2011.08.020
27 https://doi.org/10.1016/j.tox.2004.08.021
28 https://doi.org/10.1016/s0006-2952(01)00643-8
29 https://doi.org/10.1016/s1470-2045(13)70310-3
30 https://doi.org/10.1124/dmd.30.11.1149
31 https://doi.org/10.1124/mol.104.006056
32 https://doi.org/10.1158/1535-7163.mct-07-0557
33 https://doi.org/10.1158/1541-7786.mcr-05-0101
34 https://doi.org/10.1200/jco.2000.18.10.2095
35 https://doi.org/10.1200/jco.2000.18.12.2354
36 https://doi.org/10.1200/jco.2003.12.046
37 https://doi.org/10.1200/jco.2004.08.163
38 https://doi.org/10.1200/jco.2006.09.8251
39 https://doi.org/10.1200/jco.2010.34.2774
40 https://doi.org/10.2174/138161213804547268
41 https://doi.org/10.3322/canjclin.55.2.74
42 https://doi.org/10.3816/clc.2006.n.024
43 schema:datePublished 2015-07
44 schema:datePublishedReg 2015-07-01
45 schema:description PURPOSE: Cytochrome P450 1B1 (CYP1B1) is involved in the metabolism of anticancer agents; its overexpression was associated with resistance to docetaxel, a commonly used drug for second-line treatment of NSCLC. Several functional single nucleotide polymorphisms (SNPs) have been associated with CYP1B1 expression and activity. The objective of this study was to retrospectively evaluate the correlation of CYP1B1 SNPs with the outcome of NSCLC patients treated with docetaxel in second or third line. METHODS: Associations between CYP1B1 4326C>G and 4390A>G polymorphisms with response, progression-free survival (PFS) and overall survival (OS) were estimated using Pearson χ(2) test, Kaplan-Meier curves and log-rank test; a multivariate analysis was performed using Cox proportional hazards modeling. RESULTS: A total of 65 advanced NSCLC patients were enrolled into the analysis. Median age was 66 years (range 46-81). Forty-nine patients were male; only five were never smokers. Performance status (PS) was 0 in 25 patients, 1 in 28 and 2 in 12. Histology was adenocarcinoma in 28 patients, squamous carcinoma in 22, other NSCLC in the remaining 15. At univariate analysis, stage and CYP1B1 4326C>G SNPs are associated with PFS, while PS and CYP1B1 4326C>G SNPs correlated with OS. In particular, patients with CYP1B1 4326-GG genotype had shorter PFS and OS than patients with other genotypes (PFS 1.80 vs. 2.70 months, p = 0.12; OS 3.63 vs. 9.83 months, p = 0.039). CYP1B1 4326C>G SNPs were also associated with response rate. Multivariate analysis confirmed the independent prognostic/predictive role of CYP1B1 4326C>G SNPs on OS (p = 0.042) with only a trend for PFS (p = 0.083). CONCLUSIONS: CYP1B1 4326C>G polymorphism emerged as possible prognostic/predictive marker of activity and efficacy of docetaxel in NSCLC patients.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf N6754ec8e4637478f9ba2ff08ff786b65
50 Nb03db0b357784372bb9238da31915606
51 sg:journal.1313647
52 schema:name Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients
53 schema:pagination 1189-1194
54 schema:productId N11be753e4ad9416d887e84566d95b640
55 N82a6d692cbc54f89b696fac840f60425
56 N9f1334c29715468e8591d19e1905d5ed
57 Nec1e0b3d63184f0eaf337bc8f2eb4d8e
58 Nf32420d6d91c47a3bbdcf26f01f7c931
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047431410
60 https://doi.org/10.1007/s00432-014-1880-3
61 schema:sdDatePublished 2019-04-11T10:20
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher Nb0000f7ee208462ba6932f91050f76fc
64 schema:url https://link.springer.com/10.1007%2Fs00432-014-1880-3
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N0d8e477ca5fa49d699b1713eb9bea4d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Aged
70 rdf:type schema:DefinedTerm
71 N11be753e4ad9416d887e84566d95b640 schema:name dimensions_id
72 schema:value pub.1047431410
73 rdf:type schema:PropertyValue
74 N1327a2b448624d6b8c94ab668ac43cbb rdf:first sg:person.01006607213.66
75 rdf:rest N9a9932beb16c45e58d5704fa975ef5fc
76 N1727ed27c7d040c39f8cd03e2357ff15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Tumor Cells, Cultured
78 rdf:type schema:DefinedTerm
79 N172bb75d3dbf4653a24639446f7a66f9 schema:name Department of Oncology, Azienda USL 6, Viale Alfieri 36, Livorno, Italy
80 rdf:type schema:Organization
81 N22afd925d2f94f6592b822fe5e507ef6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Polymorphism, Single Nucleotide
83 rdf:type schema:DefinedTerm
84 N32f28055ad394092af5d89e5140d0956 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Female
86 rdf:type schema:DefinedTerm
87 N35d3cab3f80e442cab4e7768002aa38f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Carcinoma, Non-Small-Cell Lung
89 rdf:type schema:DefinedTerm
90 N3c76dec90a9047229e310ec02a74f228 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Prognosis
92 rdf:type schema:DefinedTerm
93 N41a2cd309cb44b938166f4e6a3815963 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Biomarkers, Pharmacological
95 rdf:type schema:DefinedTerm
96 N450b98f931de47439e4f07bf5d1e24d8 schema:affiliation https://www.grid.ac/institutes/grid.10041.34
97 schema:familyName Leon
98 schema:givenName G. Leticia
99 rdf:type schema:Person
100 N4dbda8c393a944f29d9d06d04ddac19f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Taxoids
102 rdf:type schema:DefinedTerm
103 N5c29512f95c84c08881bba1a997e0abc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Lung Neoplasms
105 rdf:type schema:DefinedTerm
106 N65e57242c1a64c9db03a98745a55eb2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Middle Aged
108 rdf:type schema:DefinedTerm
109 N6754ec8e4637478f9ba2ff08ff786b65 schema:issueNumber 7
110 rdf:type schema:PublicationIssue
111 N71b1f61b4d00462fa70f122ecfd30c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Retrospective Studies
113 rdf:type schema:DefinedTerm
114 N72b12e48f99d4c0f9035e7dbc8cf60a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Treatment Outcome
116 rdf:type schema:DefinedTerm
117 N82a6d692cbc54f89b696fac840f60425 schema:name nlm_unique_id
118 schema:value 7902060
119 rdf:type schema:PropertyValue
120 N884dfd4283234d0e9572ebdd96470ca5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Aged, 80 and over
122 rdf:type schema:DefinedTerm
123 N8d58a64aafc1422ca031400aed3aa406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Antineoplastic Agents
125 rdf:type schema:DefinedTerm
126 N9a9932beb16c45e58d5704fa975ef5fc rdf:first sg:person.0631427704.49
127 rdf:rest Nb3e85b2c3f194298967ed8df6239a4af
128 N9b942696158246309da4f195c608b0b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Docetaxel
130 rdf:type schema:DefinedTerm
131 N9f1334c29715468e8591d19e1905d5ed schema:name readcube_id
132 schema:value e1f2a7a2522e7dc9c7ff72847ade015f49a886605d5c3b4fabbe3d5bdd8f5ded
133 rdf:type schema:PropertyValue
134 Nac41e3ae7f1946638a1a9ab87628ada0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Chemotherapy, Adjuvant
136 rdf:type schema:DefinedTerm
137 Nb0000f7ee208462ba6932f91050f76fc schema:name Springer Nature - SN SciGraph project
138 rdf:type schema:Organization
139 Nb03db0b357784372bb9238da31915606 schema:volumeNumber 141
140 rdf:type schema:PublicationVolume
141 Nb3e85b2c3f194298967ed8df6239a4af rdf:first N450b98f931de47439e4f07bf5d1e24d8
142 rdf:rest Nd22a322da7ff498fadf4c7a2a7f1d218
143 Nc832ff38f91a4f0da0adc0e220afd85c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Genetic Association Studies
145 rdf:type schema:DefinedTerm
146 Nd22a322da7ff498fadf4c7a2a7f1d218 rdf:first sg:person.01152336274.29
147 rdf:rest Nd65ce436b70b463c95edb86c5da5e201
148 Nd65ce436b70b463c95edb86c5da5e201 rdf:first sg:person.0577505063.56
149 rdf:rest rdf:nil
150 Nd7428d19d4c549ff88425972b6e5511e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Cytochrome P-450 CYP1B1
152 rdf:type schema:DefinedTerm
153 Ndc90e5a2445c484bbca932829e27a000 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Humans
155 rdf:type schema:DefinedTerm
156 Ndcf690e7ef544f1b8512a7f11c66cc56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Male
158 rdf:type schema:DefinedTerm
159 Nec1e0b3d63184f0eaf337bc8f2eb4d8e schema:name doi
160 schema:value 10.1007/s00432-014-1880-3
161 rdf:type schema:PropertyValue
162 Nf32420d6d91c47a3bbdcf26f01f7c931 schema:name pubmed_id
163 schema:value 25504507
164 rdf:type schema:PropertyValue
165 Nfc702107269741c1a2c98fb220cd2f13 schema:name Department of Oncology, Azienda USL 6, Viale Alfieri 36, Livorno, Italy
166 rdf:type schema:Organization
167 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
168 schema:name Medical and Health Sciences
169 rdf:type schema:DefinedTerm
170 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
171 schema:name Clinical Sciences
172 rdf:type schema:DefinedTerm
173 sg:journal.1313647 schema:issn 0171-5216
174 1432-1335
175 schema:name Journal of Cancer Research and Clinical Oncology
176 rdf:type schema:Periodical
177 sg:person.01006607213.66 schema:affiliation https://www.grid.ac/institutes/grid.144189.1
178 schema:familyName Vasile
179 schema:givenName Enrico
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006607213.66
181 rdf:type schema:Person
182 sg:person.01152336274.29 schema:affiliation Nfc702107269741c1a2c98fb220cd2f13
183 schema:familyName D’Incecco
184 schema:givenName Armida
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152336274.29
186 rdf:type schema:Person
187 sg:person.0577505063.56 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
188 schema:familyName Giovannetti
189 schema:givenName Elisa
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0577505063.56
191 rdf:type schema:Person
192 sg:person.0631427704.49 schema:affiliation N172bb75d3dbf4653a24639446f7a66f9
193 schema:familyName Tibaldi
194 schema:givenName Carmelo
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0631427704.49
196 rdf:type schema:Person
197 sg:pub.10.1038/sj.bjc.6604195 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043379832
198 https://doi.org/10.1038/sj.bjc.6604195
199 rdf:type schema:CreativeWork
200 sg:pub.10.1186/1471-2407-10-511 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049101761
201 https://doi.org/10.1186/1471-2407-10-511
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1016/j.ab.2011.08.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004591949
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1016/j.tox.2004.08.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053362093
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1016/s0006-2952(01)00643-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047800103
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1016/s1470-2045(13)70310-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047147510
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1124/dmd.30.11.1149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041252912
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1124/mol.104.006056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004869238
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1158/1535-7163.mct-07-0557 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017134170
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1158/1541-7786.mcr-05-0101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021745176
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1200/jco.2000.18.10.2095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074640407
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1200/jco.2000.18.12.2354 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074654615
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1200/jco.2003.12.046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204000
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1200/jco.2004.08.163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016594110
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1200/jco.2006.09.8251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052156977
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1200/jco.2010.34.2774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031223413
230 rdf:type schema:CreativeWork
231 https://doi.org/10.2174/138161213804547268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069168526
232 rdf:type schema:CreativeWork
233 https://doi.org/10.3322/canjclin.55.2.74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048020321
234 rdf:type schema:CreativeWork
235 https://doi.org/10.3816/clc.2006.n.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033968801
236 rdf:type schema:CreativeWork
237 https://www.grid.ac/institutes/grid.10041.34 schema:alternateName University of La Laguna
238 schema:name Center for Biomedical Research of the Canary Islands, Instituto de Tecnologias Biomedicas, University of La Laguna, San Cristóbal de La Laguna, Spain
239 Department of Oncology, VUMC, De Boelelaan 1117, Amsterdam, The Netherlands
240 rdf:type schema:Organization
241 https://www.grid.ac/institutes/grid.144189.1 schema:alternateName Azienda Ospedaliera Universitaria Pisana
242 schema:name Division of Medical Oncology 2, Department of Oncology, Azienda Ospedaliero-Universitaria Pisana, Via Roma 67, 56126, Pisa, Italy
243 rdf:type schema:Organization
244 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
245 schema:name Department of Oncology, VUMC, De Boelelaan 1117, Amsterdam, The Netherlands
246 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...